Commentary
In this review, P. Ramadori et al. (German Center for Cancer Research (DKFZ), Heidelberg, Germany) explain the cellular crosstalk of T cells with other immune cells, regulatory networks or stimulatory effects of these interactions, and the role of the metabolic microenvironment in influencing immune cell functionality.
Finally, they present the pros and cons of the current therapeutic strategies against NAFLD-related HCC
Previous Post
Identify the risk of NASH and cirrhosis: the time to screen is now
Next Post
Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH